Filing Details
- Accession Number:
- 0001209191-15-082321
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-27 08:29:05
- Reporting Period:
- 2015-11-24
- Filing Date:
- 2015-11-27
- Accepted Time:
- 2015-11-27 08:29:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1567514 | Intra-Cellular Therapies Inc. | ITCI | Pharmaceutical Preparations (2834) | 364742850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585697 | J. Lawrence Hineline | C/O Intra-Cellular Therapies, Inc. 3960 Broadway New York NY 10032 | Vp Of Finance Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-11-24 | 5,000 | $55.00 | 59,700 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 6, 2014.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.86 to $55.05, inclusive. The reporting person undertakes to provide to Intra-Cellular Therapies, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) of this Form 4.
Billionaire Hedge Funds
